Concepedia

Tomoo Shiozawa

TS

Statistics

Publications

4

Citations

84

H-Index

4

Active since

1990

Affiliations

Daiichi Sankyo (Germany)(Current)

Daiichi-Sankyo (Japan)

Yakult Honsha (Japan)

Tomoo Shiozawa is an author at Daiichi Sankyo (Germany) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1990–2013

4

Publications

4

Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey†

Tomoo Shiozawa, Jun-ichi Tadokoro, T Fujiki et al. · Japanese Journal of Clinical Oncology · 2013 · 38 citations · Full text

Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance

Seizaburo Kashiwagi, Sanae Yoshida, Hiroki Yamaguchi et al. · Journal of Infection and Chemotherapy · 2012 · 17 citations

, , +3

Post-marketing Surveillance (PMS) of all Patients Treated with Irinotecan in Japan: Clinical Experience and ADR Profile of 13 935 Patients

Jun-ichi Tadokoro, Koji Kakihata, Masashi Shimazaki et al. · Japanese Journal of Clinical Oncology · 2011 · 15 citations · Full text

The Pharmacokinetics and Pharmacodynamics of a New Thromboxane Synthetase Inhibitor, 6-(1-Imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in Man after Repeated Oral Doses

Μakoto Tanaka, Kenji Ono, Hideo Hakusui et al. · Journal of Pharmacy and Pharmacology · 1990 · 14 citations

, , +11

1–4 of 4